Bcl-2/Bcl-xL inhibitor (Kirin)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBcl-2/Bcl-xL inhibitor (Kirin)
Drug Alias Name1133719
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis regulator Bcl-2 inhibitorsCaspase stimulants
TargetsCaspaseApoptosis regulator Bcl-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKirin Brewery Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKirin Brewery Company Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A